CRISPRES

Laura J Wagstaff1, Nadine Bestard-Cuche2, Maja Kaczmarek2

  • 1Centre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK. laura.wagstaff@ed.ac.uk.

Nature communications
|October 9, 2024
PubMed
概括

这项研究基因编辑了人类的寡头细胞原生细胞 (OPCs),以克服多发性硬化症 (MS) 病变抑制剂. 移植后编辑的OPC在动物模型中增强了回髓化,为进展性MS提供了潜在的治疗方法.

相关概念视频

CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...